logo
What the science says about dying of a broken heart

What the science says about dying of a broken heart

Euronews27-07-2025
It might actually be possible to die of a broken heart, even years after the loss of a loved one, new research suggests.
Grief is a normal response to death, but for some bereaved people, it can cause serious physical and mental health problems in both the short- and long-term.
Now, a study has found that people who suffer from consistently high levels of intense grief are more likely to die within a decade of their closest loved ones.
A Danish research team spent a decade following more than 1,700 adults who had recently lost a partner, parent, or another close relative, dividing people into five groups based on the severity and consistency of their grief symptoms over time.
Over the 10-year period, people on the 'high' grief trajectory – those with the longest-lasting, most intense grief – had a death rate that was 88 per cent higher than those with the lowest levels of grief symptoms, according to the study published in the journal Frontiers in Public Health.
Those in the high-grief group were also significantly more likely to be in therapy or taking antidepressant medicines more than three years after their loved one's death. After seven years, those differences tapered off.
Researchers don't yet know exactly why people hit hardest by grief were more likely to die in the next decade after their loved one's death.
'We have previously found a connection between high grief symptom levels and higher rates of cardiovascular disease, mental health problems, and even suicide. But the association with mortality should be further investigated,' Mette Kjærgaard Nielsen, one of the study's authors and a postdoctoral researcher at Aarhus University, said in a statement.
But she noted that people in the high-grief group tended to have lower education levels and take more mental health medicines before their loved one died.
That suggests 'that they had signs of mental vulnerability which may cause greater distress on bereavement,' Nielsen said.
Overall, participants were aged 62 on average when the study began, meaning some of their health issues could also be explained by ageing. The majority were women.
The study was also small, with just 107 people in the high-grief group and 670 people in the low-grief group. Larger studies would be needed to confirm the findings.
But the study adds to a growing body of research on how emotional shocks affect our health. One such risk is takotsubo cardiomyopathy, commonly known as broken heart syndrome, because it is associated with stressful events like the death of a loved one.
It occurs when the heart temporarily enlarges and doesn't pump well, causing heart failure that can be mistaken for a heart attack.
Women are more likely to suffer from broken heart syndrome, but men are more likely to die from the condition, according to a study published earlier this year in the Journal of the American Heart Association.
Another study found that grieving adults are more likely to die from heart disease and suicide in the three years after their spouses die. Men are also more likely to die from digestive or respiratory issues.
Nielsen said the latest results could help doctors become more aware of the signs to look out for if a patient in mourning could be at risk of having their own health deteriorate.
'They can then offer these patients tailored follow-up in general practice, or refer them to a private-practice psychologist or secondary care,' Nielsen said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Novo Nordisk keeps growing, fuelling hopes of a stock rebound
Novo Nordisk keeps growing, fuelling hopes of a stock rebound

Euronews

time20 hours ago

  • Euronews

Novo Nordisk keeps growing, fuelling hopes of a stock rebound

Novo Nordisk reported results for the first half of 2025 on Wednesday, days after issuing a profit warning that triggered a 23% single-day share price plunge — the steepest in its history. The results were broadly in line with expectations. In the first six months of 2025, Novo Nordisk's sales increased by 16% in Danish kroner and by 18% at constant exchange rates (CER) to DKK 154.9bn (€20.77bn). US sales climbed 16% in kroner (17% at CER), boosted by accounting changes. This included a DKK 3bn (€402 million) provision in the second quarter linked to the US' 340B drug discount scheme. International sales also rose 16% (19% at CER). Sales in Diabetes and Obesity care, meanwhile, grew 16% to DKK 145.4bn (€19.49bn), driven by a 56% surge in obesity treatments to DKK 38.8 billion (€5.2bn). GLP-1 diabetes drugs rose 8%, and rare disease sales increased 14%. Valuation slump In July 2024, Danish pharmaceutical giant Novo Nordisk briefly touched a €600bn valuation, becoming Europe's most valuable company and even surpassing its country's gross domestic product. Just over a year later, its market capitalisation has collapsed to around €180bn, as cracks begin to emerge in the blockbuster narrative surrounding its weight-loss drugs. Yet some Wall Street analysts argue the sell-off may have gone too far. At current levels, they suggest the company could be entering value territory, potentially offering a compelling buying opportunity. Forecasts for the year ahead Looking ahead, Novo Nordisk's 2025 sales are expected to grow 8–14% at CER, with operating profit up 10–16%. Currency effects are seen trimming those gains by 3 and 5 percentage points respectively. The lowered forecast reflects reduced demand for GLP-1 diabetes and weight-loss therapies due to alternative products from competitors — especially affecting Wegovy and Ozempic in the US and selected global markets. Meanwhile, leadership changes at Novo Nordisk will take effect this Thursday. After Lars Fruergaard Jørgensen was ousted in May linked to the firm's falling share price, Maziar Mike Doustdar will take over as CEO this week. Analysts eye buying opportunity after historic sell-off Goldman Sachs analyst James Quigley noted that the results were largely in line with the pre-release and exchange-rate pressures on operating profit were slightly less severe than initially feared. However, the firm flagged the discontinuation of several pipeline assets. These are individually minor, but collectively raising some concern about long-term research and development momentum. Quigley remained broadly optimistic on Novo Nordisk's long-term potential growth: "At the current level, we believe the sell-off is disconnected from the long-term opportunity in the obesity market, particularly given the significant manufacturing infrastructure and investments Novo is making or has already made.' Goldman Sachs acknowledged that uncertainties remain around the GLP-1 and obesity market, as well as Novo Nordisk's pipeline strength, particularly in light of the eventual semaglutide patent expiry. The firm said it would continue tracking key data points and developments closely. Still, Quigley added that, following the sharp share price drop, the risk-reward balance had shifted favourably. "On balance, we see more upside than downside risk and remain Buy-rated," the note read, with a DKK 400 (€53.62) target price implying about 29% upside from current levels. Market reaction Novo Nordisk shares were trading 2% lower during European morning trading on Wednesday, eyeing their seventh negative day out of the last eight. Shares are now down over 65% compared with a year ago.

What the science says about dying of a broken heart
What the science says about dying of a broken heart

Euronews

time27-07-2025

  • Euronews

What the science says about dying of a broken heart

It might actually be possible to die of a broken heart, even years after the loss of a loved one, new research suggests. Grief is a normal response to death, but for some bereaved people, it can cause serious physical and mental health problems in both the short- and long-term. Now, a study has found that people who suffer from consistently high levels of intense grief are more likely to die within a decade of their closest loved ones. A Danish research team spent a decade following more than 1,700 adults who had recently lost a partner, parent, or another close relative, dividing people into five groups based on the severity and consistency of their grief symptoms over time. Over the 10-year period, people on the 'high' grief trajectory – those with the longest-lasting, most intense grief – had a death rate that was 88 per cent higher than those with the lowest levels of grief symptoms, according to the study published in the journal Frontiers in Public Health. Those in the high-grief group were also significantly more likely to be in therapy or taking antidepressant medicines more than three years after their loved one's death. After seven years, those differences tapered off. Researchers don't yet know exactly why people hit hardest by grief were more likely to die in the next decade after their loved one's death. 'We have previously found a connection between high grief symptom levels and higher rates of cardiovascular disease, mental health problems, and even suicide. But the association with mortality should be further investigated,' Mette Kjærgaard Nielsen, one of the study's authors and a postdoctoral researcher at Aarhus University, said in a statement. But she noted that people in the high-grief group tended to have lower education levels and take more mental health medicines before their loved one died. That suggests 'that they had signs of mental vulnerability which may cause greater distress on bereavement,' Nielsen said. Overall, participants were aged 62 on average when the study began, meaning some of their health issues could also be explained by ageing. The majority were women. The study was also small, with just 107 people in the high-grief group and 670 people in the low-grief group. Larger studies would be needed to confirm the findings. But the study adds to a growing body of research on how emotional shocks affect our health. One such risk is takotsubo cardiomyopathy, commonly known as broken heart syndrome, because it is associated with stressful events like the death of a loved one. It occurs when the heart temporarily enlarges and doesn't pump well, causing heart failure that can be mistaken for a heart attack. Women are more likely to suffer from broken heart syndrome, but men are more likely to die from the condition, according to a study published earlier this year in the Journal of the American Heart Association. Another study found that grieving adults are more likely to die from heart disease and suicide in the three years after their spouses die. Men are also more likely to die from digestive or respiratory issues. Nielsen said the latest results could help doctors become more aware of the signs to look out for if a patient in mourning could be at risk of having their own health deteriorate. 'They can then offer these patients tailored follow-up in general practice, or refer them to a private-practice psychologist or secondary care,' Nielsen said.

Danish universities increasingly rejecting foreign researchers
Danish universities increasingly rejecting foreign researchers

Euronews

time17-07-2025

  • Euronews

Danish universities increasingly rejecting foreign researchers

Growing scrutiny against espionage is leading higher institutions of learning in Denmark to reject foreign researchers, as officials report threat levels as high. University authorities in the Nordic nation say they are particularly vigilant when researchers come from Russia, Iran, and China, as sensitive Danish research must not fall into the wrong hands. At Aarhus University, one of Denmark's foremost institutions of higher education, at least 24 foreign researchers have been rejected this year. This equates to one in twelve applicants from China, Russia, and Iran, the institution said. According to Brian Vinter, vice-dean of Aarhus University's Faculty of Engineering, the applicant researchers were rejected on the basis that they would have access to material that could lead them to divulge information to a third party. The Danish Security and Intelligence Service (PET) says there are four ways in which foreign states can exploit and pressure researchers into becoming spies. Bribery or buying access to knowledge, blackmail, threats, coercion, digital influence campaigns, and simple methods such as surveillance, theft, and burglary are among the ways it mentions. At the University of Southern Denmark, André Ken Jakobsen, associate professor at the Centre for War Studies, warns that advanced technology can be applied by many powers. "And that makes the interest bigger, the intensity bigger, the competition bigger, and thus the threat is also bigger," he said, adding that a lot of unwanted attention may arise, especially in the areas of quantum technology and the green transition. This is what has informed the need for caution, according to Professor Jakobsen. Denmark's security and defence agenda The tightened rules on this also come in light of Denmark's security and defence agenda when it took over the six-month rotating presidency of the European Union. On 3 July, Denmark marked the takeover of the Presidency of the Council of the EU with an official opening ceremony in Aarhus. While analysts believe this may particularly be geared to rearmament efforts, as the Scandinavian country tends to do with defence as a priority, associate professor Jakobsen notes that the threat of cyber espionage is real. The Danish Emergency Management Agency reports that the threat of cyber espionage and cybercrime against Danish universities is very high. That's why screenings are necessary, according to Jakobsen. Despite the efforts to mitigate risks, there are fears the situation may have some impact. "Of course, I think that's super sad because we want the best people to come in and work for us. This is also why we do everything we can to avoid overimplementation," said Vinter of the Aarhus University Technical Faculty. "But there is no doubt that we say no to some people who probably could have had employment at Aarhus University without anything going wrong with it, but we have assessed that the risk is too high," he explained. Several other Danish universities have also rejected foreign researchers for fear of espionage, but they have said they don't keep count of the number of rejections. To screen applicants, the University of Copenhagen told local media it has employed two staff members in addition to using a third-party consultancy. The majority of the screenings have been carried out in the natural and health sciences, although the university told DR, the official Danish broadcaster, that they do not have statistics on how many applications have been refused.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store